Literature DB >> 11118250

Reduced item set for the amyotrophic lateral sclerosis assessment questionnaire: development and validation of the ALSAQ-5.

C Jenkinson1, R Fitzpatrick.   

Abstract

OBJECTIVE: The 40 item amyotrophic lateral sclerosis assessment questionnaire (ALSAQ-40) is a subjective health measure designed specifically to assess areas of importance to patients with ALS. It was designed for use in surveys and clinical trials of this patient group, and has been assessed for reliability and validity. Despite its relative brevity there are situations where an even shorter form of the instrument would be desirable. Consequently, this paper reports a process of item reduction which results in a brief five item version of the instrument.
METHODS: Data from two surveys of patients with ALS who completed the ALSAQ-40 were analysed to develop a short form ALSAQ. Questionnaire items were correlated with their dimension total scores. Highly correlated items were transformed onto a scale from 0 to 100 and results compared with the parent dimension.
RESULTS: Five items were selected that produced results that closely resembled those of the five dimension scores of the ALSAQ-40.
CONCLUSIONS: Results on the new measure compared with the parent ("gold standard") ALSAQ-40 suggest that the measure can produce similar results to the longer form but with considerable economy.

Entities:  

Mesh:

Year:  2001        PMID: 11118250      PMCID: PMC1763474          DOI: 10.1136/jnnp.70.1.70

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  5 in total

1.  Evidence for the validity and reliability of the ALS assessment questionnaire: the ALSAQ-40.

Authors:  C Jenkinson; R Fitzpatrick; C Brennan; M Swash
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  1999-12

2.  Benefits and obstacles of health status assessment in ambulatory settings. The clinician's point of view. The Dartmouth Primary Care COOP Project.

Authors:  J Wasson; A Keller; L Rubenstein; R Hays; E Nelson; D Johnson
Journal:  Med Care       Date:  1992-05       Impact factor: 2.983

3.  Methodological approaches to shortening composite measurement scales.

Authors:  J Coste; F Guillemin; J Pouchot; J Fermanian
Journal:  J Clin Epidemiol       Date:  1997-03       Impact factor: 6.437

4.  The functional status of patients. How can it be measured in physicians' offices?

Authors:  E C Nelson; J M Landgraf; R D Hays; J H Wasson; J W Kirk
Journal:  Med Care       Date:  1990-12       Impact factor: 2.983

Review 5.  Early diagnosis of dementia: neuroimaging.

Authors:  P Scheltens
Journal:  J Neurol       Date:  1999-01       Impact factor: 4.849

  5 in total
  11 in total

1.  Difference in chronological changes of outcome measures between untreated and placebo-treated patients of spinal and bulbar muscular atrophy.

Authors:  Atsushi Hashizume; Masahisa Katsuno; Haruhiko Banno; Keisuke Suzuki; Noriaki Suga; Fumiaki Tanaka; Gen Sobue
Journal:  J Neurol       Date:  2011-09-28       Impact factor: 4.849

Review 2.  Clinical diagnosis and management of amyotrophic lateral sclerosis.

Authors:  Orla Hardiman; Leonard H van den Berg; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

3.  Efficacy and safety of leuprorelin acetate for subjects with spinal and bulbar muscular atrophy: pooled analyses of two randomized-controlled trials.

Authors:  Atsushi Hashizume; Masahisa Katsuno; Keisuke Suzuki; Haruhiko Banno; Yu Takeuchi; Motoshi Kawashima; Noriaki Suga; Tomoo Mano; Amane Araki; Yasuhiro Hijikata; Akihiro Hirakawa; Gen Sobue
Journal:  J Neurol       Date:  2019-03-07       Impact factor: 4.849

4.  Can item response theory reduce patient burden when measuring health status in neurological disorders? Results from Rasch analysis of the SF-36 physical functioning scale (PF-10).

Authors:  C Jenkinson; R Fitzpatrick; A Garratt; V Peto; S Stewart-Brown
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-08       Impact factor: 10.154

Review 5.  Patient-Perceived Outcomes and Quality of Life in ALS.

Authors:  Zachary Simmons
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

6.  Emotional distress and well-being among people with motor neurone disease (MND) and their family caregivers: a qualitative interview study.

Authors:  Cathryn Pinto; Adam W A Geraghty; Lucy Yardley; Laura Dennison
Journal:  BMJ Open       Date:  2021-08-17       Impact factor: 3.006

7.  Deriving summary indices of health status from the Amyotrophic Lateral Sclerosis Assessment Questionnaires (ALSAQ-40 and ALSAQ-5).

Authors:  C Jenkinson; J M Norquist; R Fitzpatrick
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

8.  Efficacy of hypnosis-based treatment in amyotrophic lateral sclerosis: a pilot study.

Authors:  Arianna Palmieri; Johann Roland Kleinbub; Vincenzo Calvo; Gianni Sorarù; Irene Grasso; Irene Messina; Marco Sambin
Journal:  Front Psychol       Date:  2012-11-05

9.  Validation of the Persian version of the 40-item amyotrophic lateral sclerosis assessment questionnaire.

Authors:  Hosein Shamshiri; Mohammad Reza Eshraghian; Nastaran Ameli; Shahriar Nafissi
Journal:  Iran J Neurol       Date:  2013

10.  Treatment with Creatine Monohydrate in Spinal and Bulbar Muscular Atrophy: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Masahisa Katsuno; Gen Sobue; Yasuhiro Hijikata; Keisuke Suzuki; Atsushi Hashizume; Amane Araki; Shinichiro Yamada; Tomonori Inagaki; Daisuke Ito; Akihiro Hirakawa; Fumie Kinoshita; Masahiko Gosho
Journal:  JMIR Res Protoc       Date:  2018-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.